Red Blood Cell Membrane-Coated Nanoparticles Enable Incompatible Blood Transfusions

Area of Science:

• Biomaterials Science
• Immunology
• Transfusion Medicine

Background:

• Blood transfusions are life-saving but limited by ABO blood group compatibility.
• Emergency situations necessitate transfusions even with incompatible blood types.
• Existing limitations highlight the need for innovative solutions to overcome transfusion barriers.

Purpose of the Study:

• To develop a biomimetic nanoplatform capable of neutralizing antibodies that cause transfusion reactions.
• To enable safe and effective transfusion of incompatible blood types.
• To investigate the efficacy and safety of the nanoplatform in preclinical models.

Main Methods:

• Fabrication of a nanoplatform using a polymeric core coated with red blood cell membranes.
• Functionalization of the nanoplatform with A-type or B-type membranes for specific antibody capture.
• Evaluation of antibody neutralization (IgM and IgG) in vitro and in vivo.
• Assessment of nanoplatform safety in murine models of passive immunization and acute hemorrhagic shock.

Main Results:

• The nanoplatform effectively captured anti-A or anti-B IgM antibodies, reducing their levels in incompatible blood.
• The nanoplatform neutralized anti-red blood cell IgG antibodies, prolonging the circulation of incompatible donor red blood cells.
• Nanoplatforms derived from expired red blood cells retained their neutralizing capacity.
• No exacerbation of inflammation, complement activation, or coagulopathy was observed in acute hemorrhagic shock models.

Conclusions:

• A biomimetic nanoplatform effectively neutralizes antibodies, facilitating incompatible blood transfusions.
• The nanoplatform demonstrates safety and efficacy in preclinical models, offering a potential solution for transfusion emergencies.
• This technology holds promise for improving patient outcomes in situations with limited compatible blood supply.